fibrinogen has been researched along with pravastatin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (40.74) | 18.2507 |
| 2000's | 14 (51.85) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eda, T; Hidaka, Y; Kamei, T; Yonemoto, M | 1 |
| Betteridge, DJ; Jay, RH; Rampling, MW | 1 |
| Braun, P; May, E; Merz, M; Park, JW; Vermeltfoort, M | 1 |
| Ayada, Y; Hosomi, N; Ichihara, S; Kawanishi, K; Kitadai, M; Sada, Y; Satoh, K; Takahashi, T; Tsuda, Y; Yamamoto, M | 1 |
| Branchi, A; Fasoli, A; Gugliandolo, AG; Rovellini, A; Sommariva, D | 1 |
| Hosomi, N; Izumi, Y; Kitadai, M; Satoh, K; Takahashi, T; Tsuda, Y | 1 |
| Ganotatis, ES; Jagroop, IA; Mikhailidis, DP; Winder, AF | 1 |
| Rosenson, RS; Tangney, CC | 2 |
| Ganotakis, ES; Mikhailidis, DP; Winder, AF | 1 |
| Ambrose, JA; Badimon, JJ; Cohen, AM; Dangas, G; Fallon, JT; Levine, D; Meraj, P; Shao, JH; Smith, DA; Unger, AH | 1 |
| Caslake, MJ; Cooney, J; Ford, I; Krishna, M; Lowe, GD; Macphee, CH; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A; Suckling, KE; Wilkinson, FE | 1 |
| Rosenson, RS; Schaefer, EJ; Tangney, CC | 1 |
| Aleixandre Porcar, L; Debón Belda, M; Martínez-Lahuerta, JJ; Murciano Revert, J | 1 |
| Balkau, B; Chesnier, MC; Eschwège, E; Maison, P; Mennen, L; Sapinho, D; Sigalas, J | 1 |
| Basso, F; Humphries, SE; Lowe, GD; McMahon, AD; Rumley, A | 1 |
| Coyle, LC; Flaherty, PJ; Kent, SM; Markwood, TT; Taylor, AJ | 1 |
| Berry, K; Burger, HG; Davis, SR; Goldstat, R; Koch, K; Meredith, I; Newman, A | 1 |
| Boekholdt, SM; de Maat, MP; Jukema, JW; Kastelein, JJ; Peters, RJ; Reitsma, PH; van Der Wall, EE; Zwinderman, AH | 1 |
| Ford, I; Lowe, GD; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A | 1 |
| Alacacioglu, A; Caliskan, S; Ceylan, C; Comlekci, A; Saklamaz, A; Temiz, A; Yesil, S | 1 |
| Badimon, L; Casani, L; Sanchez-Gomez, S; Vilahur, G | 1 |
| Cawich, I; Chen, J; Dandapat, A; Deonikar, P; Hu, CP; Kavdia, M; Marwali, MR; Mehta, JL; Mohandas, B; Sawamura, T | 1 |
| Czosnyka, M; Hutchinson, PJ; Kirkpatrick, PJ; Pickard, JD; Richards, H; Tseng, MY; Turner, CL | 1 |
| Blauw, GJ; Buckley, BM; Cobbe, S; de Craen, AJ; Ford, I; Jukema, JW; Lowe, GD; Macfarlane, PW; Murphy, MB; Murray, HM; Packard, CJ; Sattar, N; Shepherd, J; Stott, DJ; Welsh, P; Westendorp, RG | 1 |
| Guo, F; Liu, JT; Pang, XM; Wang, CJ | 1 |
| Liu, J; Lu, P; Pang, X | 1 |
1 review(s) available for fibrinogen and pravastatin
| Article | Year |
|---|---|
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.
Topics: Animals; Antithrombins; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Endothelium, Vascular; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Lovastatin; Muscle, Smooth, Vascular; Platelet Aggregation; Pravastatin; Simvastatin; Thromboplastin; Thrombosis | 1998 |
11 trial(s) available for fibrinogen and pravastatin
| Article | Year |
|---|---|
Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment.
Topics: Adult; Anticholesteremic Agents; Blood Viscosity; Cholestyramine Resin; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Middle Aged; Naphthalenes; Pravastatin; Rheology | 1990 |
Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
Topics: Acyl Coenzyme A; Blood Viscosity; Cholesterol; Enzyme Inhibitors; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipoproteinemias; Lovastatin; Male; Middle Aged; Pravastatin; Simvastatin; Triglycerides | 1996 |
Comparative study of HMG-CoA reductase inhibitors on fibrinogen.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Coronary Disease; Cross-Over Studies; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Male; Middle Aged; Pravastatin; Pyrroles; Simvastatin | 2001 |
Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS).
Topics: Anticholesteremic Agents; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Homozygote; Humans; Hypercholesterolemia; Interleukin-6; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Pravastatin | 2002 |
Effect of atorvastatin and pravastatin on serum C-reactive protein.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Carotid Arteries; Cholesterol, LDL; Female; Fibrinogen; Heptanoic Acids; Humans; Lipids; Male; Middle Aged; Pravastatin; Pyrroles; Tunica Intima | 2003 |
Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Topics: Aged; Anticholesteremic Agents; Brachial Artery; Cholesterol, HDL; Cholesterol, LDL; Diet, Reducing; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Hypercholesterolemia; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Pravastatin; Progesterone Congeners; Quality of Life; Reference Values; Regional Blood Flow | 2002 |
Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events.
Topics: Coronary Artery Disease; Disease-Free Survival; Fibrinogen; Genotype; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Pravastatin; Proportional Hazards Models; Radiography; Receptors, Fibrinogen; Risk Assessment | 2004 |
Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Case-Control Studies; Coronary Disease; Factor VII; Factor XIIa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; Monocytes; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Predictive Value of Tests; Risk Factors; Scotland; Thrombophilia; Triglycerides | 2004 |
The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Erythrocyte Deformability; Female; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pravastatin; Pyrroles; Triglycerides | 2005 |
Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Brain Ischemia; C-Reactive Protein; Cholesterol, LDL; Double-Blind Method; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemoglobins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Aneurysm; Leukocyte Count; Lipids; Logistic Models; Middle Aged; Platelet Count; Pravastatin; Risk Factors; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2007 |
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Kaplan-Meier Estimate; Male; Myocardial Infarction; Pravastatin; Risk Factors; Stroke | 2009 |
15 other study(ies) available for fibrinogen and pravastatin
| Article | Year |
|---|---|
Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733).
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Benzylamines; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Fibrinogen; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Mevalonic Acid; Muscle, Smooth, Vascular; Nifedipine; Platelet-Derived Growth Factor; Pravastatin; Simvastatin; Sterols; Swine; Thiophenes | 1992 |
Regression of transplant coronary artery disease during chronic HELP therapy: a case study.
Topics: Arteriosclerosis; Chemical Precipitation; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Extracorporeal Circulation; Fibrinogen; Follow-Up Studies; Heart Transplantation; Humans; Hypercholesterolemia; Lipoprotein(a); Male; Middle Aged; Pravastatin; Time Factors | 1995 |
Effect of medication with pravastatin sodium on hemorheological parameters in patients with hyperlipoproteinemia.
Topics: Cholesterol; Female; Fibrinogen; Hemorheology; Humans; Hyperlipoproteinemias; Male; Middle Aged; Pravastatin; Triglycerides | 1993 |
Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia.
Topics: Adult; Aged; Bezafibrate; Cholesterol, Dietary; Combined Modality Therapy; Female; Fenofibrate; Fibrinogen; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipids; Lovastatin; Male; Middle Aged; Pravastatin; Simvastatin | 1993 |
Beneficial effects of statins.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Fibrinogen; Humans; Lovastatin; Pravastatin; Serotonin; Simvastatin | 1996 |
Beneficial effects of statins.
Topics: Anticholesteremic Agents; Fibrinogen; Humans; Hypercholesterolemia; Lovastatin; Platelet Aggregation; Pravastatin; Simvastatin | 1996 |
Comment on: effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Fibrinogen; Follow-Up Studies; Hemorheology; Humans; Hyperlipoproteinemia Type II; Lovastatin; Pravastatin; Simvastatin | 1996 |
Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin.
Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Female; Fibrinogen; Fibrinolysis; Humans; Hypercholesterolemia; Male; Middle Aged; Peptide Fragments; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Pravastatin; Prothrombin; Sex Factors; Thrombin; Thrombophilia; Triglycerides | 1999 |
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Coronary Disease; Fibrinogen; Humans; Hypercholesterolemia; Inflammation; Leukocyte Count; Logistic Models; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2; Pravastatin; Risk Factors; Triglycerides | 2000 |
[Effect on plasma fibrinogen of hypercholesterolaemia treatment with pravastatin].
Topics: Anticholesteremic Agents; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Prospective Studies | 2001 |
A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration.
Topics: Adult; Body Mass Index; Cohort Studies; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; France; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Pravastatin; Sex Factors; Treatment Outcome | 2002 |
Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering.
Topics: Animals; Blood Platelets; Cholesterol, Dietary; Endothelium, Vascular; Female; Fibrinogen; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunohistochemistry; Platelet Aggregation; Pravastatin; rhoA GTP-Binding Protein; Risk; Swine; Thrombosis | 2005 |
Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Drug Therapy, Combination; Fibrinogen; Humans; Integrin alpha2beta1; Nitric Oxide; Oxidative Stress; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Pravastatin; Scavenger Receptors, Class E; Signal Transduction | 2007 |
Pravastatin inhibits C-reactive protein generation induced by fibrinogen, fibrin and FDP in isolated rat vascular smooth muscle cells.
Topics: Animals; C-Reactive Protein; Cells, Cultured; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pravastatin; Rats; Rats, Sprague-Dawley | 2012 |
Pravastatin inhibits fibrinogen- and FDP-induced inflammatory response via reducing the production of IL-6, TNF-α and iNOS in vascular smooth muscle cells.
Topics: Animals; Atherosclerosis; Cell Line; Dose-Response Relationship, Drug; Fibrin Fibrinogen Degradation Products; Fibrinogen; Inflammation; Interleukin-6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type II; Pravastatin; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2015 |